Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal-Reference-Cited by-同舟云学术

Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal

Author:

Pandey Preeti¹²,Verma Vijay³⁴,Gautam Gunjan¹,Kumari Nilima²,Dhar Suman Kumar³,Gourinath Samudrala¹

Affiliation:

1. School of Life Sciences; Jawaharlal Nehru University; New Delhi India

2. Department of Bioscience and Biotechnology; Banasthali University; Jaipur India

3. Special Centre for Molecular Medicine; Jawaharlal Nehru University; New Delhi India

4. Department of Microbiology; Central University of Rajasthan; Kishangarh India

Funder

DST-SERB

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference41 articles.

4. Escherichia coli DNA polymerase II is stimulated by DNA polymerase III holoenzyme auxiliary subunits;Hughes;J Biol Chem,1991

5. Processive DNA synthesis by DNA polymerase II mediated by DNA polymerase III accessory proteins;Bonner;J Biol Chem,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Repurposing: A Potentially Emerging Discipline;Indian Journal of Pharmaceutical Education and Research;2022-05-16